CGCN GROUP, LLC

Lobbying for PARTNER THERAPEUTICS, INC. · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $80,000.00 income · posted Jul 19, 2026

Lobbying activity 2

Health Issues

Issues pertaining to the development of public health emergency medical countermeasures. Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act.

Defense

Issues related to medical countermeasures for Acute Radiation Syndrome (ARS).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.